ZA935693B - Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists - Google Patents

Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists

Info

Publication number
ZA935693B
ZA935693B ZA935693A ZA935693A ZA935693B ZA 935693 B ZA935693 B ZA 935693B ZA 935693 A ZA935693 A ZA 935693A ZA 935693 A ZA935693 A ZA 935693A ZA 935693 B ZA935693 B ZA 935693B
Authority
ZA
South Africa
Prior art keywords
angiotensin
prodrugs
carboxylic acids
receptor antagonists
imidazole carboxylic
Prior art date
Application number
ZA935693A
Other languages
English (en)
Inventor
Robert John Ardecky
Carol Lee Ensinger
James Russell Pruitt
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of ZA935693B publication Critical patent/ZA935693B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA935693A 1992-08-06 1993-08-05 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists ZA935693B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/926,795 US5310929A (en) 1992-08-06 1992-08-06 Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists

Publications (1)

Publication Number Publication Date
ZA935693B true ZA935693B (en) 1995-02-06

Family

ID=25453732

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935693A ZA935693B (en) 1992-08-06 1993-08-05 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists

Country Status (18)

Country Link
US (1) US5310929A (OSRAM)
EP (1) EP0654027A1 (OSRAM)
JP (1) JP2892838B2 (OSRAM)
CN (1) CN1090275A (OSRAM)
AU (1) AU688735B2 (OSRAM)
BR (1) BR9306911A (OSRAM)
CA (1) CA2141692C (OSRAM)
FI (1) FI950485A7 (OSRAM)
HU (1) HU9500349D0 (OSRAM)
IL (1) IL106553A0 (OSRAM)
MX (1) MX9304787A (OSRAM)
NO (1) NO950404D0 (OSRAM)
PL (1) PL307309A1 (OSRAM)
SG (1) SG47108A1 (OSRAM)
SK (1) SK13195A3 (OSRAM)
TW (1) TW239131B (OSRAM)
WO (1) WO1994003435A1 (OSRAM)
ZA (1) ZA935693B (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
RU2109736C1 (ru) * 1992-12-17 1998-04-27 Санкио Компани Лимитед Производные бифенила и способ их получения
PT1110551E (pt) * 1994-03-16 2004-07-30 Sankyo Co Redutor de tensao ocular
US6221335B1 (en) * 1994-03-25 2001-04-24 Isotechnika, Inc. Method of using deuterated calcium channel blockers
US5510495A (en) * 1994-09-19 1996-04-23 The Du Pont Merck Pharmaceutical Company Process for the isolation and purification of ester functionalized imidazole intermediates by selective hydrolysis
DE69507887T2 (de) * 1994-09-20 1999-06-17 Wakunaga Seiyaku K.K., Osaka Verfahren zur herstellung von n-biphenylmethylthiadiazolin derivaten oder deren salzen sowie dafür benötigte zwischen verbindungen
IT1292437B1 (it) * 1997-06-30 1999-02-08 Zambon Spa Processo di orto-metallazione utile per la sintesi di 1 - tetrazol- 5-il) benzeni 2-sostituiti
IT1295405B1 (it) 1997-09-30 1999-05-12 Merck Sharp & Dohme Italia S P Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di
DE19820064A1 (de) * 1998-05-06 1999-11-11 Hoechst Marion Roussel De Gmbh Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
DE19832429A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19832428A1 (de) * 1998-07-18 2000-01-20 Hoechst Marion Roussel De Gmbh Imidazolderivate mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
ES2154191B1 (es) * 1998-11-24 2001-10-16 Ferrer Int Nuevos acetales derivados de los 2-alquil-5-halo-3-(2'-(tetrazol-5-il)-bifenil-4-ilmetil)-3h-imidazol-4-carbaldehidos.
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
AU2002257970B2 (en) 2001-05-31 2007-08-02 Vicore Pharma Ab Tricyclic compounds useful as angiotensin II agonists
CA2513373A1 (en) * 2003-01-16 2004-08-05 Teva Pharmaceutical Industries Ltd Novel synthesis of irbesartan
CA2554001A1 (en) 2004-01-20 2005-07-28 Aichi Prefecture Epitope/peptide recognized by hla-a2402-restricted ep-cam-specific ctl and use of the same
US7157584B2 (en) * 2004-02-25 2007-01-02 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
WO2006029057A1 (en) * 2004-09-02 2006-03-16 Teva Pharmaceutical Industries, Ltd. Purification of olmesartan medoxomil
US20090123538A1 (en) * 2005-04-20 2009-05-14 Alani Laman L Angiotensin II Receptor Antagonists
JP2009515834A (ja) * 2006-08-29 2009-04-16 テバ ファーマシューティカル インダストリーズ リミティド ５−フェニル−１−トリチル−１ｈ−テトラゾールの合成のための方法
CA2663981C (en) * 2006-10-09 2014-05-27 Cipla Limited Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil
WO2008067687A1 (en) * 2006-12-06 2008-06-12 Shanghai Allist Pharmaceutical., Inc. The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof
ES2768295T3 (es) 2010-01-07 2020-06-22 Alkermes Pharma Ireland Ltd Profármacos de compuestos heteroaromáticos
EP2455388A1 (en) 2010-11-23 2012-05-23 LanthioPep B.V. Novel angiotensin type 2 (AT2) receptor agonists and uses thereof.
CN104610232B (zh) * 2013-11-01 2019-09-20 深圳信立泰药业股份有限公司 阿利沙坦酯无定形及其制备方法及含所述无定形的药物组合物
EP4007592A1 (en) 2019-08-02 2022-06-08 LanthioPep B.V. Angiotensin type 2 (at2) receptor agonists for use in the treatment of cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
SG50669A1 (en) * 1989-06-30 1998-07-20 Du Pont Fused-ring aryl subtituted imidazoles
HU217958B (hu) * 1989-06-30 2000-05-28 E. I. Du Pont De Nemours And Co. Helyettesített imidazolszármazékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
GB8927277D0 (en) * 1989-12-01 1990-01-31 Glaxo Group Ltd Chemical compounds
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5137902A (en) * 1990-07-13 1992-08-11 E. I. Du Pont De Nemours And Company 4-alkylimidazole derivatives and anti-hypertensive use thereof
ATE199548T1 (de) * 1992-06-02 2001-03-15 Sankyo Co 4-carboxyimidazolderivate als angiotensin-ii- antagonisten und ihre therapeutische verwendung

Also Published As

Publication number Publication date
US5310929A (en) 1994-05-10
MX9304787A (es) 1995-01-31
PL307309A1 (en) 1995-05-15
SG47108A1 (en) 1998-03-20
CN1090275A (zh) 1994-08-03
SK13195A3 (en) 1995-07-11
EP0654027A1 (en) 1995-05-24
CA2141692C (en) 2006-05-30
JPH08500103A (ja) 1996-01-09
CA2141692A1 (en) 1994-02-17
FI950485L (fi) 1995-02-03
AU4790393A (en) 1994-03-03
BR9306911A (pt) 1998-12-08
TW239131B (OSRAM) 1995-01-21
FI950485A0 (fi) 1995-02-03
JP2892838B2 (ja) 1999-05-17
NO950404D0 (no) 1995-02-03
HU9500349D0 (en) 1995-03-28
IL106553A0 (en) 1993-12-08
AU688735B2 (en) 1998-03-19
FI950485A7 (fi) 1995-02-03
WO1994003435A1 (en) 1994-02-17

Similar Documents

Publication Publication Date Title
ZA935693B (en) Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists
AU3122793A (en) Substituted heterocycles as angiotensin ii antagonists
EP0574787A3 (en) Benzimidazole derivatives as angiotensin ii antagonists
ZA912656B (en) Substituted benzimidazoles having angiotensin 11 receptor antagonisn
AU8374491A (en) Angiotensin II receptor antagonists
HUP9902645A3 (en) Fused-ring carboxylic acid derivatives
AU3276293A (en) Angiotensin II receptor antagonists
EP0711162A4 (en) POSITION 5 SUBSTITUTED IMIDAZOLES AS ANGIOTENSIN II ANTAGONISTS
IL131812A0 (en) Salt of naphthyridine carboxylic acid derivative
ZA923279B (en) Substituted carboxylic acid derivatives
GB9317758D0 (en) Angiotensin ii antagonist
AU5455194A (en) Substituted phthalazinones as nerotensin antagonists
HU9202817D0 (en) Bicyclical carboxylic acid derivatives
GB9521696D0 (en) Combination of LTD4 receptor antagonists with glucocorticosteriods
AU3440693A (en) Substituted 1-isoquinolone derivatives as angiotensin II antagonists
IL129135A0 (en) 3-Alkoxyisoxazol-4- YL-substituted 2-amino carboxylic acid compounds
IL109310A0 (en) Alkyl substituted nitroimidazole acetic acids
EP0591891A3 (en) Benzimidazole derivatives as angiotensin ii antagonists
FI943808L (fi) Triatsolopyrimidiinijohdannaisia angiotensiini II:n reseptoreiden vastavaikuttajina
IL110239A0 (en) Azacyclic - heterocyclic compounds as angiotensin II receptor antagonists
EP0546449A3 (en) Benzofuranderivatives as angiotensin ii antagonists
EP0595151A3 (en) Imidazopyridine derivates as antagonists of angiotensin ii
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
GB2264708B (en) Carboxylic acid esters of hydroxyphenylalkanols as stabilisers
IL123213A0 (en) Carboxylic acid derivatives